MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: GTCbio - Biopharmaceutical Conference
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Shafique Virani, Global Head at Roche to Speak at CNS Partnering Meeting September 22-23 in San Francisco - Shafique Virani, Global Head of CNS Business Development & Licensing at F. Hoffmann-La Roche, to give featured presentation at 4th CNS Partnering and Deal-making Conference (Sept 22-23, in San Francisco, CA)
Shafique Virani, Global Head at Roche to Speak at CNS Partnering Meeting September 22-23 in San Francisco

 

NewswireToday - /newswire/ - Monrovia, CA, United States, 2011/06/24 - Shafique Virani, Global Head of CNS Business Development & Licensing at F. Hoffmann-La Roche, to give featured presentation at 4th CNS Partnering and Deal-making Conference (Sept 22-23, in San Francisco, CA).

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Shafique Virani, Global Head of CNS Business Development & Licensing at F. Hoffmann-La Roche will give a featured presentation on “Partnering in Neurodegenerative Diseases: The Roche-Remynd Deal” at the 4th CNS Partnering and Deal-making Conference to be held in San Francisco, CA on September 22-23, 2011 by GTC.

Shafique Virani will discuss F. Hoffmann-La Roche’s new strategic approach in partnerships with Neuroscience companies focusing on novel therapeutic targets and approaches for Alzheimer’s Disease.

Highlights of Shafique Virani’s presentation:

• Alzheimer’s Disease is a devastating clinical condition with no currently available therapies which slow down disease progression;
• Disease modification approaches have traditionally centered on modulating the Beta amyloid pathway;
• To date, none of these approaches have been clinically validated and the failure of late stage trials is high;
• There remains a strong desire to explore other avenues for disease modification, eg modulating mis-folded protein toxicity and clearance; inhibiting protein aggregation and reducing downstream inflammation.

Shafique Virani is the Global Head of CNS Business Development & Licensing at Roche. His responsibilities in this role encompass all partnering activities within Roche’s neuroscience franchise from academic collaborations to licensing and acquisitions. Dr. Virani joined Roche in 2004 and served various roles within medical affairs and business development in the UK and USA until 2010, when he transitioned into his current role based in Basel, Switzerland. Dr. Virani trained as a neurosurgeon in Cambridge, UK and Boston, USA and holds the Fellowship of the Royal College of Surgeons of England.

The 4th CNS Partnering and Deal-making Conference gives global biotechnology and pharmaceutical companies in the CNS industry an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, as well as explore potential collaborations, and learn about relevant CNS Disease issues and partnerships that will affect the industry.

This event also provides a unique venue for attendees to learn about CNS Diseases business trends, the CNS disease market, and novel technologies that shape up the industry. The conference is part of the CNS Diseases World Summit, which consists of 3 tracks including the “5th Neurodegenerative Conditions Research and Development” and “Advances in Neuropsychiatric Treatment”.

The sessions for the conferences are:
• Plenary Keynote Session
• Regulatory Updates
• Strategic Direction in Neuroscience
• Case Studies in the Clinical Space
• Recent Advances in CNS Development
• Investments and Partnerships in the CNS Space
• Current Trends and Recent Deals.

For more information, please visit gtcbio.com/.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Shafique Virani, Global Head at Roche to Speak at CNS Partnering Meeting September 22-23 in San Francisco

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

DSM Boosts Maternal and Infant Nutrition Portfolio with New Plant-based High Potency DHA Oil
Ipsen Enters into an Option Agreement with IRICoR and Université de Montréal for A Discovery-stage Oncology Program
Ipsen Announces Positive Topline Results from Pivotal Phase III CheckMate -9ER Trial Evaluating CABOMETYX®
Ipsen Data Presented During ENETS Annual Conference 2020 Capture New Patient and Healthcare Professional Insights in the Treatment of NETs
Global Pharmaceutical Contract Manufacturing Organization Market to Reach 2.14 Billion by 2024 Finds Frost & Sullivan
Ipsen’s Palovarotene Clinical Program in Fibrodysplasia Ossificans Progressiva Reaches Prespecified Interim Analysis Futility Criteria
Global Bio-based Chemicals Market is Expected to Grow At A CAGR of 16.67% by 2027 According to Inkwood Research
Global Diabetes Drugs Market Forecast 2019-2027 Reports Inkwood Research
Dysport® Now Approved in the UK for Symptomatic Treatment of Upper Limb Spasticity in Children with Cerebral Palsy
Human Microbiome Market to Reach .08 Billion by 2023, Powered by the High Growth in Over-the-Counter Probiotics Finds Frost & Sullivan
BASF Launches Hepacor in Switzerland for the Dietary Management of Non-Alcoholic Fatty Liver Disease
FDA Grants Priority Review to Genentech’s Risdiplam for Spinal Muscular Atrophy
Ipsen Presents New Analyses Utilizing Modern Data Mining Approaches At ISPOR Europe 2019
Global Opioids Drugs Market is Projected to Grow At a CAGR of 2.52% by 2027 Reports Inkwood Research
Global Bio-Based Chemicals Market Projected to Grow At a CAGR of 16.67% by 2027 Finds Inkwood Research

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  BizJobs.com





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)